Related Experiment Video
Updated: Dec 1, 2025

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
Published on: April 26, 2015
Effects of ω-3 PUFA and ascorbic acid combination on post-resuscitation myocardial function.
Cheng Cheng1, Hui Li2, Lian Liang3
1Department of Cardiology, The Second Hospital of Anhui Medical University, Hefei, China; Weil Institute of Emergency and Critical Care Research, Virginia Commonwealth University, Richmond, VA, USA.
Omega-3 polyunsaturated fatty acid (PUFA) and ascorbic acid (AA) improve survival after cardiac arrest (CA). Combining ω-3 PUFA and AA offers enhanced protection against myocardial dysfunction and inflammation post-resuscitation.
Area of Science:
- Cardiovascular Research
- Emergency Medicine
- Biochemistry
Background:
- Cardiac arrest (CA) and subsequent cardiopulmonary resuscitation (CPR) often lead to myocardial dysfunction and organ damage.
- Administration of ω-3 polyunsaturated fatty acid (ω-3 PUFA) or ascorbic acid (AA) has shown promise in improving outcomes after CA.
- The combined effects of ω-3 PUFA and AA on myocardial function and microcirculation following CA/CPR are not well understood.
Purpose of the Study:
- To investigate the effects of ω-3 PUFA combined with AA on myocardial function after CA and CPR in a rat model.
- To evaluate the impact of these treatments on sublingual microcirculation, lipid peroxidation, and systemic inflammation.
Main Methods:
- Thirty male rats were randomized into five groups: sham, control, ω-3 PUFA, AA, and ω-3 PUFA + AA.
- Ventricular fibrillation was induced, followed by 8 minutes of CPR, with drug or vehicle infusion at the start of CPR.
- Myocardial function, sublingual microcirculation, and biochemical markers were assessed after return of spontaneous circulation (ROSC).
Main Results:
- Both ω-3 PUFA and AA significantly improved myocardial function and sublingual microcirculation compared to the control group post-ROSC.
- The combination of ω-3 PUFA + AA demonstrated superior improvement in myocardial function compared to either agent alone.
- ω-3 PUFA or AA reduced pro-inflammatory cytokines, cardiac troponin I (cTnI), and markers of lipid peroxidation (MDA, 4-HNE). The combination therapy showed a greater reduction in MDA and 4-HNE.
Conclusions:
- ω-3 PUFA and AA treatment mitigate post-resuscitation myocardial dysfunction, enhance microcirculation, and reduce oxidative stress and inflammation.
- Combined ω-3 PUFA and AA administration provides an additive benefit in suppressing lipid peroxidation and improving myocardial recovery.
- This combination therapy represents a promising strategy for improving outcomes following cardiac arrest and resuscitation.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Coronary Syndrome IV: Interprofessional Care